logo

For the Inventor, By the Inventor

Inashiki, Japan

Akira Hatta

This inventor holds 3 USPTO granted patents. Top assignee: Tsumura Co., Ltd.. Active years: 1993-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Hatta. Retrieved from https://idiyas.com/inventor/akira-hatta-zshsuhr4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal3 out of 60 
 
Tsumura Co., Ltd.
 patents

Years Active: 1993-1995

Loading Chart...
3 patents (USPTO):Explore Patents
1. 5459160 - Iridoid derivatives and the use thereof as a drug (1995-10-17),
2. 5374653 - Iridoid derivatives and the use thereof as a drug (1994-12-20),
3. 5272172 - Iridoid derivatives and the use thereof as a drug (1993-12-21),

Title: Akira Hatta: Innovator in Iridoid Derivatives

Introduction

Akira Hatta is a notable inventor based in Inashiki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on iridoid derivatives. With a total of 3 patents to his name, Hatta's innovations are paving the way for new therapeutic agents.

Latest Patents

Hatta's latest patents focus on iridoid derivatives synthesized using genipin, an aglycon of geniposide. These compounds are recognized for their potential as anti-hyperlipemia agents and cholagogues. His research highlights the therapeutic applications of these derivatives, showcasing their importance in modern medicine.

Career Highlights

Hatta is currently associated with Tsumura Co., Ltd., where he continues to advance his research. His work has garnered attention for its innovative approach to drug development, particularly in addressing metabolic disorders.

Collaborations

Hatta collaborates with esteemed colleagues, including Ichiro Arai and Masaharu Kigawa. Their combined expertise enhances the research and development efforts at Tsumura Co., Ltd.

Conclusion

Akira Hatta's contributions to the field of pharmaceuticals through his work on iridoid derivatives are noteworthy. His innovative research continues to impact the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…